- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Autoimmune Bullous Dermatosis in New Zealand
Total 2312 results
-
University at BuffaloCompletedMultiple SclerosisUnited States
-
University of RochesterTerminatedMultiple SclerosisUnited States
-
BiogenElan PharmaceuticalsCompletedMultiple SclerosisUnited States
-
City University of New YorkRecruitingMultiple Sclerosis,Gait, ExerciseUnited States
-
Columbia UniversityNational Multiple Sclerosis SocietyCompleted
-
Transparency Life SciencesUnknownMultiple Sclerosis, Relapsing-RemittingUnited States
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
State University of New York at BuffaloBiogenCompletedMultiple SclerosisUnited States
-
Multiple Sclerosis Center of Northeastern New YorkBiogenCompletedMultiple SclerosisUnited States
-
Weill Medical College of Cornell UniversityGenzyme, a Sanofi CompanyCompletedMultiple SclerosisUnited States
-
Actavis Inc.CompletedActinic KeratosisUnited States
-
University of RochesterPfizerCompletedSleep Disturbance | Pruritus | Atopic DermatitisUnited States
-
Keith Edwards, M.D.EMD SeronoRecruitingMultiple SclerosisUnited States
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
NYU Langone HealthCompletedMultiple SclerosisUnited States
-
National Center for Research Resources (NCRR)University of PennsylvaniaUnknownMultiple SclerosisUnited States
-
Amicus TherapeuticsCompletedEpidermolysis BullosaUnited States
-
Arcutis Biotherapeutics, Inc.CompletedAtopic Dermatitis EczemaUnited States, Canada
-
NYU Langone HealthCompletedPediatric Multiple SclerosisUnited States
-
State University of New York at BuffaloCompleted
-
University of RochesterForest LaboratoriesCompleted
-
Image Dermatology P.C.CompletedOpen-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of IntertrigoIntertrigoUnited States
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedAtopic DermatitisUnited States, Canada
-
Regeneron PharmaceuticalsSanofiCompletedConjunctivitis | Atopic DermatitisUnited States
-
LEO PharmaCompleted
-
Apogee Therapeutics, Inc.Recruiting
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedAtopic DermatitisUnited States
-
Kessler FoundationConsortium of Multiple Sclerosis CentersRecruitingMultiple SclerosisUnited States
-
Kessler FoundationRecruiting
-
Novartis PharmaceuticalsCompleted
-
Kessler FoundationCompletedMultiple SclerosisUnited States
-
Novartis PharmaceuticalsCompleted
-
Kessler FoundationCompleted
-
Kessler FoundationNational Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
Stony Brook UniversityTeva Pharmaceuticals USACompleted
-
Kessler FoundationNational Multiple Sclerosis SocietyCompleted
-
Kessler FoundationEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Stony Brook UniversityWithdrawn
-
Kessler FoundationNational Multiple Sclerosis SocietyRecruitingMultiple SclerosisUnited States
-
Kessler FoundationNational Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
Taro Pharmaceuticals USACompletedDermatitis, AtopicUnited States
-
Regeneron PharmaceuticalsSanofiRecruitingModerate-to-Severe Atopic Dermatitis | Atopic EczemaUnited States
-
Kessler FoundationNational Multiple Sclerosis SocietyRecruitingMultiple SclerosisUnited States
-
NYU Langone HealthGenentech, Inc.CompletedMultiple SclerosisUnited States
-
Kessler FoundationUniversity of Illinois at Urbana-ChampaignCompletedMultiple SclerosisUnited States
-
Kessler FoundationCompleted
-
Actavis Inc.Completed
-
LEO PharmaCompletedAtopic DermatitisUnited States, Canada
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisUnited States, Italy, United Kingdom, Spain, Japan, Canada, Netherlands, New Zealand, Hungary, Czechia, Poland, Australia, Romania, Korea, Republic of